Please assess the completion status of the following clinical trial:

Trial Title: MOTO Post-marketing Surveillance Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients with unicompartmental tibiofemoral osteoarthritis (OA) of the knee that meet the indications for use of Medacta implant included in this study (on-label use);~* Patients suffering from unilateral osteoarthritis or osteonecrosis of a single knee compartment;~* Frontal deformity \< 10° (evaluated on weight-bearing long-axis x-rays);~* Flexion contracture \< 10°;~* Intact ligaments;~* Patients willing and able to provide written informed consent for participation in the study;~* Patient's age over 18 years old;~* Patient with BMI \< 40 kg/m2;~* Patients willing to comply with the pre and post-operative evaluation schedule.~Exclusion Criteria:~* Patients with one or more medical conditions identified as a contraindication in the labelling on any Medacta implants used in this study;~* Any patient who cannot or will not provide informed consent for participation in the study;~* Patients who need a revision surgery;~* Patients who had previously undergone high tibial osteotomy or anterior cruciate ligament (ACL) reconstruction;~* Patients with BMI ≥ 40 kg/m2;~* Patients unable to understand and take action;~* Any case not described in the inclusion criteria.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- MOTO medial (Type: None): Patients suitable fulfilling the standard criteria for the implantation of unicondylar implant.

Based on this trial design, predict the completion outcome and termination type (if applicable).